Dr. Janicek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10197 N 92nd St #101
Scottsdale, AZ 85258Phone+1 480-993-2950
Education & Training
- University of Miami/Jackson Health SystemFellowship, Gynecologic Oncology, 1993 - 1996
- Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1989 - 1993
- Harvard Medical SchoolMD, Infectious Diseases, cum laude, 1985 - 1989
- Harvard Medical SchoolClass of 1989
- Harvard CollegeBA, Biochemistry, magna cum laude, 1981 - 1985
Certifications & Licensure
- AZ State Medical License 1998 - 2025
- FL State Medical License 1993 - 2000
- PA State Medical License 1992 - 1998
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Doc 10 Consecutive Years, Top Vote Recipient Phoenix Magazine, 2011-2021
- Regional Top Doctor Castle Connolly, 2014
- Career Development Award American Cancer Society, 1996, 1997, 1998
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsIn vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinomaMarilu Madrigal, Mike F. Janicek, Bernd-Uwe Sevin, James P. Perras, Ricardo Estape
Gynecologic Oncology. 1997-01-01 - 15 citationsCombination Anti-Gene Therapy Targeting c-myc and p53 in Ovarian Cancer Cell LinesMike F. Janicek, Bernd-Uwe Sevin, Hoa N. Nguyen, Hervy E. Averette
Gynecologic Oncology. 1995-10-01 - 45 citationsOverexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Res...Setsuko K. Chambers, Mary C Clouser, Amanda F. Baker, Denise J. Roe, Haiyan Cui
Clinical Cancer Research. 2010-11-01
Journal Articles
- Cervical cancer: prevention, diagnosis, and therapeutics.Janicek MF, Averette HE, CA Cancer J Clin. 2001 Mar-Apr;51(2):92-114; quiz 115-8
- Management of Colouterine Fistulas.Estape RE, Angioli R, Janicek MF, Madrigal ML, Medina C, Penalver M, Journal of Pelvic Surgery 2000: 6(3), 170-173
- Critical care issues in cervical cancer management.Mirhashemi R, Janicek MF, Schoell WM, Semin Surg Oncol. 1999 Apr-May;16(3):267-74
Books/Book Chapters
Abstracts/Posters
- The National Cancer Data Base report on ovarian cancer.Averette HE, Janicek MF, Menck HR., Cancer 76(6):1096-103, American College of Surgeons Commission on Cancer and the American Cancer Society
- Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Safety and ...A. Gordon, M. Teneriello, P. Lim, M. Janicek, T. Burkholder, Y. Wang, M. Orlando, C. Obasaju, J. Gill, D. Tai, ASCO
- Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Interim anal...A. N. Gordon, M. G. Teneriello, N. Spirtos, M. F. Janicek, T. Goss, Y. Wang, M. Orlando, C. K. Obasaju, J. F. Gill and D. F. Tai, Journal of Clinical Oncology, 2008 ASCO Annual Meeting, Vol 26, No 15S (Supplement), 5536
Lectures
- Diagnosis and Management of Gynecologic and Breast Cancer: An Update.Alexander Hotel Miami Beach, Florida
- Ovarian Cancer: Update.Memorial Regional Hospital Hollywood, Florida
- Cytoprotectants in Gyn Oncology.Maricopa County/St. Joe's Hosp, Phoenix, AZ
- Join now to see all
Press Mentions
- To Host State of the Science Summit™: The Treatment of Gynecologic CancerMarch 28th, 2018
- The 100 Best Doctors in Arizona for 2024December 15th, 2023
Professional Memberships
- Fellow
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: